Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

Date Posted: 
2014-09-26

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men.

Co-lead by Drs. Paul Rennie, Art Cherkasov & Emma Tomlinson-Gun, the project "Pre-clinical development of the next-generation anti-androgens for the treatment of drug-resistant and advanced prostate cancer" is one of only two grants awarded. The three-year grant is for $1,463,090 starting on October 1, 2014.

Click here to read the Prostate Cancer Canada press release of this funding award.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.